What is McKesson's u.s. pharmaceutical — total assets?

McKesson (MCK) reported u.s. pharmaceutical — total assets of $46.81B in Q1 2024.

What does u.s. pharmaceutical — total assets mean?

The total value of all resources and assets owned and utilized by the U.S. Pharmaceutical business segment.

Discontinued — last reported Q1 '24

U.S. Pharmaceutical — Total Assets

McKesson U.S. Pharmaceutical — Total Assets increased by 12.0% to $46.81B in Q1 2024 compared to the prior quarter.

Analysis

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ1 2020

Last reportedQ1 2024

Rolls up toTotal Assets

How to read this metric

An increase suggests business expansion or higher investment in working capital, while a decrease may signal divestitures or improved asset turnover efficiency.

Detailed definition

This metric represents the aggregate value of all assets, including inventory, accounts receivable, property, plant, and...

Peer comparison

Major pharmaceutical wholesalers typically report segment assets to demonstrate the scale of their distribution network and inventory management capabilities relative to their peers.

Metric ID: mck_segment_u_s_pharmaceutical_total_assets

Historical Data

3 periods

	Q1 '22	Q1 '23	Q1 '24
Value	$38.35B	$41.79B	$46.81B
QoQ Change	—	+9.0%	+12.0%
YoY Change	—	+9.0%	+12.0%

Range$38.35B – $46.81B

Avg YoY Growth+10.5%

Median YoY Growth+10.5%

Current Streak2+ quarters growth

Similar Metrics at Other Companies

AbbottABT View metric

UnitedHealth GroupUNH View metric

Thermo Fisher ScientificTMO View metric

UnitedHealth GroupUNH View metric

Eli LillyLLY View metric

AbbVieABBV View metric

Frequently Asked Questions

What is McKesson's u.s. pharmaceutical — total assets?: McKesson (MCK) reported u.s. pharmaceutical — total assets of $46.81B in Q1 2024.
What does u.s. pharmaceutical — total assets mean?: The total value of all resources and assets owned and utilized by the U.S. Pharmaceutical business segment.